Promethazine Clinical Prior Authorization Criteria Updates Scheduled for Dec. 7

Published on
November 10, 2021

HHSC will remove the following products from the Promethazine/Promethazine Containing Products prior authorization criteria guide:

  • Promethazine VC syrup
  • Promethazine VC-codeine syrup
  • Promethazine-codeine syrup
  • Promethazine-DM syrup

This revision is necessary to ensure the appropriate prior authorization duration and age-based prescribing restrictions. The cough and cold criteria guide contains criteria for promethazine VC syrup and promethazine-DM syrup. However, Promethazine VC-codeine syrup and promethazine-codeine syrup are not included in the cough and cold criteria guide. These agents contain codeine and are not intended for patients under 18 years of age.

Additionally, the title of clinical prior authorization criteria will change to Promethazine Agents. Implementation of Promethazine Agents is required by all MCOs and effective by Dec. 7, 2021.